All studied groups | Control group | Reactive Group | APLS | |||||
---|---|---|---|---|---|---|---|---|
r | P-value | r | P-value | r | P-value | r | P-value | |
Age (years) | 0.069 | 0.519 | − 0.116 | 0.627 | 0.104 | 0.664 | −0.011 | 0.941 |
HB (g/dL) | −0.371** | 0.000 | −0.387 | 0.091 | −0.244 | 0.301 | 0.116 | 0.428 |
WBCs (×103/ul) | 0.139 | 0.193 | 0.104 | 0.661 | −0.041 | 0.864 | 0.146 | 0.317 |
NE (×103/ul) | 0.132 | 0.217 | −0.006 | 0.981 | −0.080 | 0.738 | 0.082 | 0.576 |
N/L ratio | 0.079 | 0.459 | −0.127 | 0.592 | −0.126 | 0.596 | −0.012 | 0.937 |
PLTs (×103/ul) | −0.190 | 0.074 | −0.051 | 0.832 | −0.192 | 0.419 | 0.212 | 0.144 |
PT (min) | 0.219* | 0.039 | −0.002 | 0.994 | −0.055 | 0.818 | 0.306* | 0.032 |
INR | 0.248* | 0.020 | 0.266 | 0.256 | −0.331 | 0.167 | 0.283* | 0.049 |
PTT (min) | 0.136 | 0.216 | 0.295 | 0.207 | −0.062 | 0.794 | −0.159 | 0.298 |
CRP (mg/dL) | 0.133 | 0.230 | 0.189 | 0.424 | −0.064 | 0.787 | −0.320* | 0.036 |
ESR mm/hour | 0.442** | 0.000 | −0.425 | 0.062 | 0.152 | 0.524 | 0.242 | 0.093 |
MPO (ng/ml) | 0.836** | 0.000 | 0.161 | 0.497 | 0.659** | 0.002 | 0.798** | 0.000 |